PLSE Q3 2021 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q3 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$574,000

Gross Profit

-$153,000-26.7% margin

Operating Income

-$14M-2486.6% margin

Net Income

-$14M-2488.2% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$67M

Total Liabilities

$20M

Stockholders' Equity

$47M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$574,000	$0	—
Gross Profit	-$153,000	$0	—
Operating Income	-$14M	-$13M	-10.6%
Net Income	-$14M	-$13M	-10.7%

Revenue Segments

Systems Products

$490,00085%

Cycle Units Products

$84,00015%

Geographic Segments

North America

$405,00071%

Non Us

$169,00029%